Akso Health Group
Statements
Ratios
Valuation ratios (P/E, P/S, EV/EBITDA and the other multiples) are based on the closing price at the end of each period, not on the current price. Margins and returns are shown in percent, multiples without a unit, per-share figures in the reporting currency, net debt in millions.
Tick rows to compare them in a chart (up to 4)
| Line item | Q2 15 | Q3 15 | Q4 15 | Q1 16 | Q2 16 | Q3 16 | Q4 16 | Q1 17 | Q2 17 | Q3 17 | Q4 17 | Q1 18 | Q2 18 | Q3 18 | Q4 18 | Q1 19 | Q2 19 | Q3 19 | Q4 19 | Q1 20 | Q2 20 | Q3 20 | Q4 20 | Q1 21 | Q2 21 | Q3 21 | Q4 21 | Q1 22 | Q2 22 | Q3 22 | Q4 22 | Q2 23 | Q4 23 | Q2 24 | Q4 24 | Q2 25 | Q4 25 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Valuation | ||||||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | – | – | – | – | 3.6 | 27.6 | 2.1 | 2.3 | 2.1 | 31.1 | – | – | – | – | – | – | – | – | – | – | – | 0.5 | 0.8 | 0.6 | 0.3 | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | 2.2 | 16.8 | 1.2 | 1.0 | 0.5 | 2.8 | 2.7 | 1.6 | 1.1 | 0.9 | 0.8 | 0.6 | 1.0 | – | – | – | – | 1.9 | 1.9 | 0.4 | 0.2 | 0.2 | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | 1.6 | 12.9 | 1.1 | 1.0 | 0.3 | 1.4 | 0.3 | 0.2 | 0.3 | 0.4 | 0.5 | 0.3 | 0.8 | 5.1 | 0.5 | 0.6 | 0.8 | 0.9 | 2.3 | 0.7 | 0.3 | 0.5 | 0.1 | 0.3 | 2.4 | 2.2 | 2.5 | 6.0 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 1.0 | 0.8 | 0.8 | – | -0.3 | 0.5 | 0.9 | – | – | – | – | 4.4 | 1.9 | 0.4 | 0.3 | 0.3 | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 16.2 | 1.3 | 2.5 | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -81.4% | – | – | – | – | – | – | |
| Margins | ||||||||||||||||||||||||||||||||||||||
| – | – | – | 100.0% | 93.3% | 86.0% | 80.1% | 77.5% | 83.7% | 88.0% | 91.1% | 94.0% | 95.5% | 94.7% | 93.2% | 90.6% | 56.4% | 58.7% | 70.6% | 80.4% | 50.0% | 46.4% | -5.2% | – | – | – | – | 105,184,586.4% | 53,458,416.7% | 35,835,671.8% | 41,409,033.8% | 9.4% | – | – | – | – | – | – | |
| – | – | – | 34.8% | 38.0% | 41.3% | 41.2% | 43.3% | 54.8% | 62.2% | 69.1% | 70.7% | 70.7% | 55.1% | 31.6% | 8.3% | -265.1% | -203.2% | -200.0% | -436.7% | -542.6% | -793.5% | -813.7% | – | – | – | – | 65.1% | 65.5% | 93.9% | 86.3% | -64.8% | – | – | – | – | – | – | |
| – | – | – | 29.7% | 32.6% | 32.8% | 29.6% | 37.4% | 47.3% | 54.6% | 60.5% | 61.1% | 60.0% | 44.5% | 23.3% | 9.0% | -214.5% | -156.6% | -263.4% | -515.3% | -649.0% | -637.3% | -544.1% | – | – | – | – | 386.3% | 241.0% | 70.3% | 58.6% | -56.4% | – | – | – | – | – | – | |
| – | – | – | 58.1% | 30.4% | 25.8% | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -16.8% | – | – | – | – | – | – | |
| Returns | ||||||||||||||||||||||||||||||||||||||
| – | – | – | 25.3% | 32.1% | 34.3% | – | 36.5% | 49.2% | 59.4% | 44.3% | 46.8% | 52.4% | 43.8% | 16.4% | 4.4% | -27.3% | -24.2% | -79.3% | -233.2% | -420.6% | -321.9% | -409.2% | – | – | – | – | 188.7% | 287.0% | 124.8% | 102.3% | -140.0% | – | – | – | – | – | – | |
| – | – | – | 15.8% | – | 19.8% | – | 30.2% | 40.4% | 44.4% | 36.4% | 40.0% | 45.4% | 37.4% | 14.3% | 3.2% | -21.3% | -18.2% | -47.4% | -143.1% | -189.1% | -144.7% | -223.0% | – | – | – | – | 45.7% | 136.1% | 59.2% | 43.6% | -43.3% | – | – | – | – | – | – | |
| Balance Sheet & Debt | ||||||||||||||||||||||||||||||||||||||
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -24 | -12 | -3.8 | – | -19 | -1.9 | -2.2 | -5.1 | -3.5 | -5.5 | 19 | 15 | -0.3 | -0.3 | 1.8 | 0.8 | -83 | -87 | -174 | -176 | 2.2 | 0.2 | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -0.2 | -0.1 | 1.0 | – | – | – | – | – | – | – | |
| – | – | 62.6% | 62.6% | – | 57.7% | – | 82.8% | 82.2% | 74.8% | 82.1% | 85.4% | 86.7% | 85.3% | 87.6% | 73.0% | 78.0% | 75.3% | 59.8% | 61.4% | 45.0% | 45.0% | 54.5% | 54.5% | 60.1% | 60.1% | 19.6% | 24.2% | 47.4% | 47.4% | 42.6% | 30.9% | 97.4% | 94.2% | 92.6% | 92.6% | 95.4% | 95.4% | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | 0.0 | 0.0 | 0.1 | – | 0.1 | 0.7 | 0.8 | 0.6 | 0.6 | 0.5 | 3.0 | 3.0 | 1.0 | 1.0 | 1.1 | 1.9 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | |
| Per Share | ||||||||||||||||||||||||||||||||||||||
| – | – | – | 0.76 | 0.85 | 1.05 | 1.08 | 1.61 | 3.39 | 5.74 | 9.20 | 1.23 | 14.65 | 10.38 | 3.63 | 0.32 | -5.80 | -4.48 | -7.03 | -6.90 | -20.94 | -16.03 | -13.04 | – | – | – | – | 3.50 | 1.24 | 1.62 | 1.17 | -0.96 | – | – | – | – | – | – | |
| – | – | – | 2.54 | 2.60 | 3.19 | 3.65 | 4.30 | 7.16 | 10.52 | 15.21 | 2.01 | 24.41 | 23.31 | 15.59 | 3.53 | 2.70 | 2.86 | 2.67 | 1.34 | 3.23 | 2.51 | 2.40 | – | – | – | – | 0.91 | 0.52 | 2.31 | 2.00 | 1.70 | – | – | – | – | – | – | |
| 0.72 | – | 3.00 | 3.00 | 2.63 | 3.05 | – | 4.41 | 6.88 | 9.67 | 20.76 | 2.63 | 27.97 | 23.67 | 22.16 | 7.28 | 21.22 | 18.51 | 8.87 | 2.96 | 4.98 | 4.98 | 3.19 | 0.35 | 3.47 | 3.47 | 2.00 | 1.85 | 0.43 | 1.30 | 1.14 | 0.69 | 5.81 | 2.58 | 0.59 | 0.59 | 0.63 | 0.25 | |
| – | – | – | 1.48 | 0.79 | 0.83 | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | – | -0.29 | – | – | – | – | – | – | |
Data as of: October 8, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.